Mucosal BCG Vaccination Induces Protective Lung-Resident Memory T Cell Populations against Tuberculosis

Mucosal BCG Vaccination Induces Protective Lung-Resident Memory T Cell Populations against Tuberculosis

ABSTRACT Mycobacterium bovis Bacille Calmette-Guérin (BCG) is the only licensed vaccine against tuberculosis (TB), yet its moderate efficacy against pulmonary TB calls for improved vaccination strategies. Mucosal BCG vaccination generates superior protection against TB in animal models; however, the...

Full description

Bibliographic Details
Main Authors:	Carolina Perdomo, Ulrike Zedler, Anja A. Kühl, Laura Lozza, Philippe Saikali, Leif E. Sander, Alexis Vogelzang, Stefan H. E. Kaufmann, Andreas Kupz
Format:	Article
Language:	English
Published:	American Society for Microbiology 2016-12-01
Series:	mBio
Online Access:	https://journals.asm.org/doi/10.1128/mBio.01686-16

Similar Items

A Mouse Model of Latent Tuberculosis Infection to Study Intervention Strategies to Prevent Reactivation.
by: Andreas Kupz, et al.
Published: (2016-01-01)

Mycobacterium tuberculosis infection modulates adipose tissue biology.
by: Macarena Beigier-Bompadre, et al.
Published: (2017-10-01)

Human and Mouse Hematopoietic Stem Cells Are a Depot for Dormant Mycobacterium tuberculosis.
by: Julia Tornack, et al.
Published: (2017-01-01)

Vaccination Against Tuberculosis: Revamping BCG by Molecular Genetics Guided by Immunology
by: Stefan H. E. Kaufmann, et al.
Published: (2020-02-01)

Mycobacteria-Specific T Cells Are Generated in the Lung During Mucosal BCG Immunization or Infection With Mycobacterium tuberculosis
by: Juan I. Basile, et al.
Published: (2020-10-01)

Repurposing mucosal delivery devices for live attenuated tuberculosis vaccines
by: Munish Puri, et al.
Published: (2023-03-01)

BCG Vaccination Prevents Reactivation of Latent Lymphatic Murine Tuberculosis Independently of CD4+ T Cells
by: Harindra D. Sathkumara, et al.
Published: (2019-03-01)

Pivotal role of tissue-resident memory lymphocytes in the control of mucosal infections: can mucosal vaccination induce protective tissue-resident memory T and B cells?
by: Stephanie Longet, et al.
Published: (2023-09-01)

Mucosal Resident memory CD4 T cells in protection and immunopathology
by: Damian Lanz Turner, et al.
Published: (2014-07-01)

BCGΔBCG1419c increased memory CD8+ T cell-associated immunogenicity and mitigated pulmonary inflammation compared with BCG in a model of chronic tuberculosis
by: Kee Woong Kwon, et al.
Published: (2022-09-01)

BCG vaccine and pulmonary tuberculosis
by: SH Tafreshi
Published: (2017-05-01)

Communication between human dendritic cell subsets in tuberculosis: requirements for naive CD4+ T cell stimulation
by: Laura eLozza, et al.
Published: (2014-07-01)

Exploiting albumin as a mucosal vaccine chaperone for robust generation of lung-resident memory T cells
by: Rakhra, Kavya, et al.
Published: (2021)

Immunogenicity and protective efficacy of prime-boost regimens with recombinant (delta)ureC hly+ Mycobacterium bovis BCG and modified vaccinia virus ankara expressing M. tuberculosis antigen 85A against murine tuberculosis.
by: Tchilian, E, et al.
Published: (2009)

Miliary Tuberculosis Due to BCG Immunotherapy
by: Bilgehan AYGEN, et al.
Published: (1996-03-01)

Intranasal mucosal boosting with an adenovirus-vectored vaccine markedly enhances the protection of BCG-primed guinea pigs against pulmonary tuberculosis.
by: Zhou Xing, et al.
Published: (2009-06-01)

Erratum: Immunogenicity and protective efficacy of prime-boost regimens with recombinant δureC hly+ Mycobacterium bovis BCG and modified Vaccinia virus Ankara expressing M. tuberculosis antigen 85A against murine tuberculosis
by: Tchilian, E, et al.
Published: (2011)

Recombinant BCG: Innovations on an old vaccine. Scope of BCG strains and strategies to improve long lasting memory
by: Adeliane C da Costa, et al.
Published: (2014-04-01)

Extracellular forms of Mycobacterium bovis BCG in the mucosal lymphatic tissues following oral vaccination
by: Wenzel Czepluch, et al.
Published: (2013-01-01)

Revisiting the Chingleput BCG vaccination trial for the impact of BCG revaccination on the incidence of tuberculosis disease
by: Banurekha Velayutham, et al.
Published: (2023-01-01)

Randomised controlled trial of single BCG, repeated BCG, or combined BCG and killed Mycobacterium leprae vaccine for prevention of leprosy and tuberculosis in Malawi
by: Fine, P, et al.
Published: (1996)

Enhanced protection conferred by mucosal BCG vaccination associates with presence of antigen-specific lung tissue-resident PD-1+ KLRG1− CD4+ T cells
by: Bull, N, et al.
Published: (2018)

CXCR3 Provides a Competitive Advantage for Retention of <i>Mycobacterium tuberculosis</i>-Specific Tissue-Resident Memory T Cells Following a Mucosal Tuberculosis Vaccine
by: Ellis Armitage, et al.
Published: (2023-09-01)

Fighting Tuberculosis: In Search of a BCG Replacement
by: Nonna I. Nadolinskaia, et al.
Published: (2022-12-01)

Spectrum of Tuberculosis in BCG Vaccinated and Unvaccinated Children
by: Najaf Masood
Published: (2010-12-01)

Spectrum of Tuberculosis in BCG Vaccinated and Unvaccinated Children
by: Najaf Masood
Published: (2010-12-01)

Features of the development of tuberculosis in children not vaccinated with BCG
by: O. M. Raznatovska, et al.
Published: (2018-07-01)

Deletion of <italic toggle="yes">nuoG</italic> from the Vaccine Candidate <named-content content-type="genus-species">Mycobacterium bovis</named-content> BCG Δ<italic toggle="yes">ureC</italic>::<italic toggle="yes">hly</italic> Improves Protection against Tuberculosis
by: Martin Gengenbacher, et al.
Published: (2016-07-01)

Distinct effector memory CD4+ T cell signatures in latent Mycobacterium tuberculosis infection, BCG vaccination and clinically resolved tuberculosis.
by: Toidi Adekambi, et al.
Published: (2012-01-01)

Immunogenicity and Protective Efficacy of Prime-Boost Regimens with Recombinant Delta ureC hly(+) Mycobacterium bovis BCG and Modified Vaccinia Virus Ankara Expressing M. tuberculosis Antigen 85A against Murine Tuberculosis, (vol 77, pg 630, 2009)
by: Tchilian, E, et al.
Published: (2011)

Tuberculosis vaccine strain <it>Mycobacterium bovis </it>BCG Russia is a natural <it>recA </it>mutant
by: Böttger Erik C, et al.
Published: (2008-07-01)

Spore-FP1 tuberculosis mucosal vaccine candidate is highly protective in guinea pigs but fails to improve on BCG-conferred protection in non-human primates
by: Andrew D. White, et al.
Published: (2023-10-01)

BCG vaccine-induced mucosal humoral immunity in human nasal associated lymphoid tissue
by: Talal M. Aljeraisi, et al.
Published: (2023-08-01)

Boosting BCG with MVA85A: the first candidate subunit vaccine for tuberculosis in clinical trials.
by: Mcshane, H, et al.
Published: (2005)

A lipidated peptide of Mycobacterium tuberculosis resuscitates the protective efficacy of BCG vaccine by evoking memory T cell immunity
by: Pradeep K. Rai, et al.
Published: (2017-10-01)

What lies beneath the airway mucosal barrier? Throwing the spotlight on antigen‐presenting cell function in the lower respiratory tract
by: Saparna Pai, et al.
Published: (2020-01-01)

Stability of the Industrial Reference Standard of Tuberculosis Vaccine (BCG)
by: N. V. Aleksandrova, et al.
Published: (2020-09-01)

BCG vaccination strategies against tuberculosis: updates and perspectives
by: Mengjin Qu, et al.
Published: (2021-12-01)

Contemporary aspects of tuberculosis in children without BCG vaccination
by: M. N. Kondаkovа, et al.
Published: (2021-04-01)

Prevention of tuberculosis in macaques after intravenous BCG immunization
by: Darrah, Patricia A., et al.
Published: (2020)